GenCell Ltd.

As of June 30, 2026, GenCell Ltd. carries a market capitalization of 3.93B, placing it among publicly traded companies globally. Its enterprise value stands at 7.99B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of June 30, 2026, GenCell Ltd. has 45.52M shares outstanding.

These figures are as of June 30, 2026.

As of June 30, 2026, GenCell Ltd. maintains a current ratio of 1.54, meaning it holds 1.5x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended June 30, 2026.

As of the close on October 22, 2026, GenCell Ltd.'s stock has declined approximately 25.99% over the past 52 weeks. The 50-day moving average sits at 77.64, while the 200-day moving average is 101.64.

As of June 30, 2026, GenCell Ltd. holds 631.20M in cash and equivalents against 4.70B in total debt, resulting in a net debt position of -631.20M. Total book value stands at 3.71B, with working capital of 486.20M providing operational flexibility.

GenCell Ltd.'s most recent stock split took place on October 19, 2025 with a 5:1 split ratio.